JA
GILD icon

John Armitage’s Gilead Sciences GILD Stock Holding History

John Armitage’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,397,732
Closed -$117M – 29
2016
Q2 		$117M Sell
1,397,732
-3,123,953
-69% -$277M 1.31% 24
2016
Q1 		$415M Buy
4,521,685
+230,218
+5% +$20.8M 3.96% 10
2015
Q4 		$434M Sell
4,291,467
-1,299,329
-23% -$135M 4.5% 9
2015
Q3 		$549M Buy
5,590,796
+1,591,342
+40% +$177M 6.2% 3
2015
Q2 		$468M Buy
3,999,454
+3,209,057
+406% +$351M 5.93% 3
2015
Q1 		$77.6M Sell
790,397
-366,367
-32% -$37.2M 1.06% 25
2014
Q4 		$109M Sell
1,156,764
-4,542,556
-80% -$470M 1.46% 24
2014
Q3 		$607M Sell
5,699,320
-449,423
-7% -$44M 8.16% 2
2014
Q2 		$510M Buy
+6,148,743
New +$479M 8.07% 2

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

John Armitage's GILD Position: Q3 2016 in Review

John Armitage sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 1,397,732 shares — an estimated $117M sold.

John Armitage first reported a position in GILD in Q2 2014 and held it in 9 quarters. The position peaked at $607M in Q3 2014. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • John Armitage reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • John Armitage sold 1,397,732 Gilead Sciences shares in Q3 2016, an estimated $117M.
  • John Armitage first reported a position in Gilead Sciences in Q2 2014 and held it in 9 quarters.
  • John Armitage's Gilead Sciences position peaked at $607M in Q3 2014.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Egerton Capital (UK)'s 13F filing for Q3 2016, filed 3 Nov 2016.